Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment

Table 2

Number of patients (N), mean IOP, standard deviation of IOP (SD), Wilcoxon values comparing base IOP values and, at different time points, mean number of antiglaucoma medications with standard deviations (meds), Me (median of meds), and the last two columns present statistical values of based on Mann–Whitney U test regarding IOP and medications. Statistical significance was when and was denoted with asterisk () where appropriate.

	Phacocanaloplasty					Phaco-deep sclerectomy					value
	N	IOP; mean ± SD	IOP; Wilcoxon	Meds; mean ± SD	Meds; Me	N	IOP; mean ± SD	IOP; Wilcoxon	Meds; mean ± SD	Meds; Me	IOP	Meds
Preop	37	19.4 ± 5.8		2.6 ± 0.9	3.0	38	19.7 ± 5.4		2.9 ± 0.9	3.0	0.639	0.197
1_d	37	12.1 ± 6.0	0.000	0.0 ± 0.0	0.0	38	12.1 ± 5.7	<0.001	0.0 ± 0.0	0.0	0.983	1.000
7_d	36	15.2 ± 6.8	0.002	0.2 ± 0.8	0.0	38	11.7 ± 4.3	<0.001	0.0 ± 0.0	0.0	0.023	0.149
1_m	36	11.5 ± 3.8	<0.001	0.1 ± 0.4	0.0	38	12.2 ± 4.0	<0.001	0.0 ± 0.0	0.0	0.735	0.143
3_m	36	11.8 ± 3.3	<0.001	0.0 ± 0.2	0.0	38	12.8 ± 3.6	<0.001	0.0 ± 0.3	0.0	0.330	0.985
6_m	34	13.0 ± 3.2	<0.001	0.2 ± 0.5	0.0	37	14.2 ± 3.0	<0.001	0.2 ± 0.6	0.0	0.042	0.639
12_m	33	13.0 ± 3.0	<0.001	0.2 ± 0.6	0.0	37	14.6 ± 3.0	<0.001	0.5 ± 0.9	0.0	0.037	0.218
18_m	30	13.3 ± 4.0	<0.001	0.2 ± 0.7	0.0	33	15.5 ± 3.0	<0.001	0.9 ± 1.0	1.0	0.001	0.001
24_m	30	13.8 ± 3.3	<0.001	0.5 ± 0.9	0.0	34	15.1 ± 3.0	<0.001	1.1 ± 1.2	1.0	0.048	0.058